Children's Hospital Westmead Clinical School, Discipline of Child & Adolescent Health, the University of Sydney, Sydney, New South Wales, Australia.
Kids Rehab, the Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Dev Med Child Neurol. 2022 Dec;64(12):1507-1516. doi: 10.1111/dmcn.15303. Epub 2022 Jun 5.
To compare biofeedback assisted relaxation training (BART) with distraction therapy for pain during botulinum neurotoxin A (BoNT-A) treatment.
This was a crossover randomized controlled trial. Eligible participants were 7 years and older with neurological conditions. Participants were randomized to receive BART or distraction during their first BoNT-A treatment, followed by the alternative intervention in their subsequent BoNT-A treatment. BART was delivered via BrightHearts, an interactive heart-rate-responsive application. Outcomes were pain (Faces Pain Scale - Revised), fear (Children's Fear Scale), and anxiety (numerical rating scale, State-Trait Anxiety Inventory). Demographics, paired t-tests, and linear mixed models were used to compare outcomes.
Thirty-eight participants (mean [SD] age 13 years 5 months [3 years 4 months], 20 males, 34 with cerebral palsy) completed both interventions. There were non-significant differences in overall pain (mean difference - 0.05, 95% confidence interval [CI] -0.91 to 0.80, p = 0.902) and worst pain (mean difference 0.37, 95% CI -0.39 to 1.13, p = 0.334) when using BART and distraction therapy. There were non-significant differences in fear and anxiety between interventions. Younger age, heightened pre-procedural state anxiety, and Gross Motor Function Classification System levels III and IV were associated with poorer outcomes (p < 0.05). Participants who received BART before distraction therapy reported lower pain and anxiety scores during both BoNT-A treatments (p < 0.05).
Children reported similar pain when using BART and distraction therapy. Those who used BART before distraction therapy reported lower pain and anxiety during both treatments.
Children reported similar pain (overall; worst) when using biofeedback assisted relaxation training (BART) and distraction therapy. Children who used BART before distraction therapy reported lower pain and anxiety over both botulinum neurotoxin A treatments. Younger age, pre-procedural state anxiety, and Gross Motor Function Classification System levels III and IV predicted a worse pain experience. Distraction therapy and BART were acceptable non-pharmacological interventions for procedural pain management.
比较生物反馈放松训练(BART)与分散注意力疗法在肉毒毒素 A(BoNT-A)治疗中的疼痛缓解效果。
这是一项交叉随机对照试验。符合条件的参与者为 7 岁及以上患有神经疾病的儿童。参与者随机接受 BART 或分散注意力治疗,作为其首次 BoNT-A 治疗的干预手段,随后在后续 BoNT-A 治疗中接受另一种干预手段。BART 通过 BrightHearts 进行,这是一种交互式心率反应应用程序。主要结局为疼痛(面部疼痛评分修订版)、恐惧(儿童恐惧量表)和焦虑(数字评分量表、状态-特质焦虑量表)。采用描述性统计、配对 t 检验和线性混合模型对结果进行比较。
38 名参与者(平均[标准差]年龄 13 岁 5 个月[3 岁 4 个月],20 名男性,34 名脑瘫患儿)完成了两项干预措施。BART 和分散注意力治疗的总体疼痛(平均差值-0.05,95%置信区间[CI]-0.91 至 0.80,p=0.902)和最痛(平均差值 0.37,95%CI-0.39 至 1.13,p=0.334)差异无统计学意义。两种干预措施在恐惧和焦虑方面差异无统计学意义。年龄较小、术前状态焦虑较高以及粗大运动功能分级系统(GMFCS)水平 III 和 IV 与较差的结局相关(p<0.05)。与接受分散注意力治疗前先接受 BART 治疗的参与者相比,在两次 BoNT-A 治疗中报告的疼痛和焦虑评分较低(p<0.05)。
儿童在使用 BART 和分散注意力治疗时报告的疼痛相似。先接受 BART 治疗的儿童在两种治疗中均报告较低的疼痛和焦虑评分。
与分散注意力治疗相比,儿童在使用生物反馈放松训练(BART)时报告的疼痛相似。先接受 BART 治疗的儿童在两种 BoNT-A 治疗中均报告较低的疼痛和焦虑评分。年龄较小、术前状态焦虑和 GMFCS 水平 III 和 IV 预测疼痛体验更差。分散注意力治疗和 BART 是用于管理程序性疼痛的可接受的非药物干预措施。